Loading organizations...
Loading organizations...
Developer of patient-specific immunotherapies for cancer treatment.
Achilles Therapeutics has raised $206.8M across 3 funding rounds.
Achilles Therapeutics has raised $206.8M in total across 3 funding rounds.
Achilles Therapeutics has raised $206.8M in total across 3 funding rounds.
Achilles Therapeutics's investors include Boxer Capital, OrbiMed, Forbion, Invus, Perceptive Advisors, RA Capital Management, Redmile Group, Syncona, Derek DiRocco, Rogier Rooswinkel, Martin Murphy, Cancer Research Horizons.
Achilles Therapeutics has raised $206.8M across 3 funding rounds. Most recently, it raised $69.8M Series C in November 2020.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Nov 19, 2020 | $69.8M Series C | Boxer Capital, OrbiMed | Forbion, Invus, Perceptive Advisors, RA Capital Management, Redmile Group, Syncona |
| Sep 3, 2019 | $120.8M Series B | Derek DiRocco | Rogier Rooswinkel, Invus, Perceptive Advisors, Redmile Group, Martin Murphy |
| Nov 1, 2016 | $16.1M Other Equity | Cancer Research Horizons, Syncona, UCL | Francis Crick Institute, UCL Business |